Eduard Vasilevskiy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Eduard Vasilevskiy has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Muzaffar Jo‘rAyev
Andijan State Medical Institute, Andijan, Uzbekistan
1 shared publication - Omonjon Dadaboyev
Andijan State Medical Institute, Andijan, Uzbekistan
1 shared publication - Sevara B. Azimova
Tashkent State Medical University, Tashkent, Uzbekistan
1 shared publication
Latest Publications
- 1 January 2026
- Published by Bukhara State Medical Institute named after Abu Ali ibn Sino in Scientific and Innovative Therapy
- Vol. 5 (2) , 812-830
SOD2 AND eNOS GENE POLYMORPHISMS AS PREDICTORS OF OXIDATIVE STRESS AND ENDOTHELIAL DYSFUNCTION IN CYTOMEGALOVIRUS INFECTION
Genotyping was performed in 100 patients with CMV infection (Group I - latent form, Group II - manifest persistent form) and 80 individuals of the control group. It was established that the Val/Val genotype of the SOD2 gene (39.6% vs. 22.5%; OR=2.27; p=0.03) and the T allele of the eNOS gene (36.2% vs. 19.4%; OR=2.47; p=0.001) are significantly associated with the risk of infection manifestation. The highest increase in the risk allele frequency was recorded for the SOD2 polymorphism (Δ16.3%), indicating the key role of antioxidant defense deficiency in the pathogenesis of persistence. The findings justify the inclusion of oxidative stress and endothelial dysfunction markers into a prognostic panel for assessing the risk of CMV progression.
- 1 January 2026
- Published by Bukhara State Medical Institute named after Abu Ali ibn Sino in Scientific and Innovative Therapy
- Vol. 5 (2) , 812-830
SOD2 AND eNOS GENE POLYMORPHISMS AS PREDICTORS OF OXIDATIVE STRESS AND ENDOTHELIAL DYSFUNCTION IN CYTOMEGALOVIRUS INFECTION
Genotyping was performed in 100 patients with CMV infection (Group I - latent form, Group II - manifest persistent form) and 80 individuals of the control group. It was established that the Val/Val genotype of the SOD2 gene (39.6% vs. 22.5%; OR=2.27; p=0.03) and the T allele of the eNOS gene (36.2% vs. 19.4%; OR=2.47; p=0.001) are significantly associated with the risk of infection manifestation. The highest increase in the risk allele frequency was recorded for the SOD2 polymorphism (Δ16.3%), indicating the key role of antioxidant defense deficiency in the pathogenesis of persistence. The findings justify the inclusion of oxidative stress and endothelial dysfunction markers into a prognostic panel for assessing the risk of CMV progression.